Additive effect of indomethacin and methotrexate on suppression of growth in rats

Biopharmaceutics and Drug Disposition

Volumn 20, Issue 8, 1999, Pages 389-395

  Iqbal, M Perwaiz ^a   Abdul Saeed, S ^a   Pertani, Shamim ^a   Mehboobali, Naseema ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Folate antagonists; Growth of rats; Indomethacin; Methotrexate; Nonsteroidal anti inflammatory drugs; Suppression of growth

Indexed keywords

INDOMETACIN; METHOTREXATE;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FLUID INTAKE; FOOD INTAKE; GROWTH RETARDATION; MALE; NONHUMAN; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY WEIGHT; DRINKING; DRUG INTERACTIONS; EATING; FOLIC ACID ANTAGONISTS; GROWTH; INDOMETHACIN; MALE; METHOTREXATE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0343962176     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-081X(199911)20:8<389::AID-BDD201>3.0.CO;2-1     Document Type: Article

References (32)

1. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. New Engl J Med 1983; 309: 1094-1104.
2. Rose CD, Padman RN, Wesdock KA, Singsen BH. Methotrexate safety in juvenile rheumatoid arthritis (JRA). Arthritis Rheum 1990; 33: S95 (abstract).
3. Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newmen AJ, Cassidy JT, Zemel LS. Methotrexate in resistant juvenile rheumatoid arthritis - results of the USA-USSR double-blind, placebo-controlled trial. New Engl J Med 1992; 326: 1043-1049.
4. Rose CD, Singsen BH, Eichenfield AH, Goldsmith DP, Athreya BH. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 1990; 117: 653-659.
5. White PH, Ansell BM. Methotrexate for juvenile rheumatoid arthritis. New Engl J Med 1992; 326: 1077-1078.
6. Giannini EH, Brewer EJ, Shaikov A, Kuzmina N, Maximov A. Low dose methotrexate in recalcitrant JRA - results of the USA-USSR randomized controlled trial. Arthritis Rheum 1991; 34: 53.
7. Wallace CA, Bleyer WA, Sherry DD, Salmonson KL, Wedgwood RJ. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum 1989; 32: 677-681.
8. Maiche AG. Acute renal failure due to concomitant action of methotrexate and indomethacin. Lancet 1986; I: 1390 (letter).
9. Singh RR, Malavia AN, Pandey JN, Guleria JS. Fatal interaction between methotrexate and naproxen. Lancet 1986; I: 1390 (letter).
10. Thyss A, Milano G, Kubar J, Namer M, Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986; I: 256-258.
11. Freeman-Narrod M, Narrod SA, Yarbro JW. Choline antagonism of methotrexate liver toxicity in the rat. Med Paed Oncol 1977; 3: 9-14.
12. Rothenberg SP, Iqbal MP, daCosta M. Effect of folate compounds on the accumulation of methotrexate and the activity of dihydrofolate reductase in liver, kidney and small intestine of the mouse. J Pharmacol Exp Ther 1982; 223: 631-634.
13. Rothenberg SP, Iqbal MP, daCosta M. Ligand-binding radioassay for the antifolate compounds. Application in patients receiving methotrexate. Cancer Treat Rep 1977; 61: 575-584.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
15. Werkheiser WC. Specific binding of 4-amino folic acid analogues by folic acid reductase. J Biol Chem 1961; 236: 888-893.
16. McBurney MW, Whitmore GF. Mechanism of growth inhibition by methotrexate. Cancer Res 1975; 35: 586-590.
17. Möell C, Garwicz S. High-dose methotrexate causes short term suppression of growth in rabbits. Acta Paediatr 1995; 84: 1237-1240.
18. Suzuki Y, Nakagawa M, Masuda C, Ide M, Uehara R, Ichikawa Y, Mizushima Y. Short term low dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant induced arthritis. J Rheumatol 1997; 24: 1890-1895.
19. Zaloga GP, Roberts P, Black KW, Prielipp R. Gut bacterial translocation + dissemination explains the increased mortality produced by parenteral nutrition following methotrexate. Circulatory Shock 1983; 39: 263-288.
20. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In Goodman and Gilman's The Pharmacological Basis of Therapeutic (9th edn), Hardman JG, Limbird LE (eds). McGraw-Hill: New York, 1995; 633-634.
21. Morgan SL, Baggott JE, Altz-Smith M. Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy. Arthritis Rheum 1987; 30: 1348-1356.
22. Bennett A, Gaffen JD, Melhuish PB, Stamford IF. Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate. Br J Pharmacol 1987; 91: 229-235.
23. Dupuis LL, Koren G, Shore A, Silverman ED, Laxer RM. Methotrexate - nonsteroidal anti-inflammatory drug interaction in children with arthritis. J Rheumatol 1990; 17: 1469-1473.
24. Nierenberg DW. Competitive inhibition of methotrexate accumulation in rabbit kidney slices by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1983; 226: 1-6.
25. Statkevich P, Fournier DJ, Sweeney KR. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney. J Pharmacol Exp Ther 1993; 265: 1118-1124.
26. Blakley RL. The Biochemistry of Folic Acid and Related Pteridines. North-Holland Publishing Co.: Amsterdam, 1969; 477-483.
27. Tsukamoto I, Kojo S. Effects of methotrexate on rat liver regeneration after partial hepatectomy. Clin Sci Colch 1992; 82: 181-184.
28. May KP, West SG, McDermott MT, Huffer WE. The effect of low dose of methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 1994; 37: 201-206.
29. 3. J Bone Miner Res 1995; 10: 874-876.
30. Kirk J, Raghupathy AP, Stevens MM, Cowell CT, Menser MA, Bergin M, Tink A, Vines RH, Silink M. Growth failure and growth hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987; I: 190-193.
31. Clayton PE, Shalet SM, Morris-Jones PH, Price DA. Growth in children treated for acute lymphoblastic leukaemia. Lancet 1988; I: 460-462.
32. Wallace CA. The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum 1998; 41: 381-391.